• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Big Pharma - Articles and news items

Patient View

New study: ‘The Corporate Reputation of Pharma in 2014 – the Patient Perspective’

Industry news / 13 February 2015 / PatientView

An independent study by PatientView…

GlobalData US pharma market value

Experts make pharma predictions for 2015: The good, the bad and the ugly

Industry news / 2 February 2015 / CPhI Worldwide

Experts from CPhI Worldwide have shared their pharma predictions for 2015, suggesting that Continuous Manufacturing and QbD will expand, with FDA becoming ‘industry tutor’. However, pharma concerns about supply chain persist…

GlobalData

Orphan drug prices facing increased scrutiny after historic year for approvals, says GlobalData analyst

Industry news / 21 January 2015 / GlobalData

With the US Food and Drug Administration (FDA) approving an all-time record number of orphan drugs during 2014, the pricing of these treatments is set to come under increased scrutiny, says an analyst with research and consulting firm GlobalData…

GlobalData

Patent cliff means pharmaceutical companies will lose $65 billion by 2019, says GlobalData

Industry news / 11 December 2014 / GlobalData

Pharmaceutical companies will suffer an estimated $65 billion drop in sales by 2019 due to the patent expiries of several leading drugs, according to research and consulting firm GlobalData…

Pin in map of Germany on Munich

Munich named as top location for biotechnology and pharmaceutical industries

Industry news / 24 November 2014 / BioM Biotech Cluster Development GmbH

Munich is the top location for biotechnology and pharmaceutical industries according to a new study by the Chamber of Industry and Commerce (IHK)…

Pills

Pharmaceutical industry doing more to improve access to medicine in developing countries; performance on some aspects lags

Industry news / 19 November 2014 / The Access to Medicine Index

The world’s leading pharmaceutical companies are doing more to improve access to medicine in developing countries, with a raft of new initiatives, scale-ups and innovations over the last two years…

PharmSource

Big bio/pharma would rather ‘make than buy,’ says PharmSource

Industry news / 13 November 2014 / PharmSource

Leader in contract bio/pharma industry intelligence predicts ongoing in-house manufacture…

Allen Burgenson, Lonza Walkersville

Is Big Pharma still actively engaging in outsourcing?

Supplier news / 19 February 2014 / Allen L. Burgenson, Manager - Regulatory Affairs, Lonza Walkersville, Inc

Allen L. Burgenson, Manager – Regulatory Affairs, Lonza Walkersville, Inc answers the question “From a vendor perspective, do you conclude that Big Pharma is still actively engaging in outsourcing of the activities that you have expertise in?”

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +